Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 622 participants.
Also called NCT01762163
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 622 participants
- Registry
-
NCT01762163
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01762163. Randomized; quadruple masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2016-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Qizhitongluo Capsule
- Intervention (Drug)
- Naoxintong Capsule
- Intervention (Drug)
- Aspirin Enteric-coated Tablets
- Intervention (Behavioral)
- the routine recovery training
- Intervention (Drug)
- placebo
- Lead sponsor
- China Academy of Chinese Medical Sciences
Record details
- Record id
cardio:ct-nct01762163- Content hash
b3668b290fa9d6dd0ae7de4c10874fee8a853f71fdba1d70aabaf055603bc9a6